Physician profile
Lydia Sauer
NPI 1346869815
$4,653.79
in general payments reported to CMS, 2019-2025
18 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.06 · 2022: $103 · 2023: $535 · 2024: $2,498 · 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,070 · Travel and Lodging: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,070.13 |
| Travel and Lodging | $1,407.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,997.21 | 2023-2024 | Clareon, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $419.48 | 2023-2025 | Stellaris, Xipere, Stellaris |
| Regeneron Healthcare Solutions, INC. | $265.47 | 2025 | Eylea Hd |
| Apellis Pharmaceuticals, INC. | $243.80 | 2024-2025 | Syfovre |
| Alimera Sciences, INC. | $236.98 | 2024 | Yutiq, Iluvien |
| Abbvie INC. | $214.55 | 2023-2025 | Xen Glaucoma Treatment System |
| Ani Pharmaceuticals, INC. | $201.06 | 2025 | Iluvien, Yutiq |
| Dutch Ophthalmic, USA | $200.55 | 2023-2024 | Eva, Combined Machine, Tissueblue |
| New World Medical,INC. | $197.38 | 2023-2024 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Astellas Pharma US INC | $150.00 | 2025 | Izervay |
| Coherus Oncology, INC. | $135.00 | 2023 | |
| Eyepoint US, INC. | $88.39 | 2022 | |
| Heidelberg Engineering, INC. | $88.00 | 2025 | Spectralis |
| Samsara Vision | $59.38 | 2025 | Implantable Miniature Telescope (Imt By Dr. Isaac Lipshitz) |
| Glaukos Corporation | $49.48 | 2022-2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $46.58 | 2021 | |
| Neurotech Pharmaceuticals, INC. | $34.00 | 2025 | |
| Genentech USA, INC. | $26.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lydia Sauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.